Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

New study tracks Real-World use of upadacitinib for ulcerative colitis in china

NCT ID NCT06838845

First seen Nov 26, 2025 · Last updated May 25, 2026 · Updated 14 times

Summary

This study will observe how well the drug upadacitinib works for Chinese adults with moderate to severe ulcerative colitis, a chronic inflammatory bowel disease. About 80 participants who are already prescribed the drug by their doctor will be followed for up to one year. The study only collects data from regular clinic visits, so there is no extra burden on participants.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ULCERATIVE COLITIS are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Study contacts

  • Contact

    Email: •••••@•••••

Locations

  • The First Affiliated Hospital, Sun-Yat Sen University /ID# 272997

    RECRUITING

    Guangzhou, Guangdong, 510080, China

  • The Second Affiliated Hospital Of Zhengzhou University /ID# 274754

    RECRUITING

    Zhengzhou, Henan, 450014, China

  • The Sixth Affiliated Hospital of Sun Yat-sen University /ID# 274753

    RECRUITING

    Guangzhou, Guangdong, 510655, China

Conditions

Explore the condition pages connected to this study.